
    
      This is a single-arm, non-randomized Phase II trial of docetaxel given every 3 weeks with
      metformin twice daily and Prednisone twice daily. The study duration of this trial is open
      ended. The patient would take the metformin only for as long as they are treated with
      docetaxel.
    
  